| Previous close | 8.22 |
| Open | 8.20 |
| Bid | 7.63 x 500 |
| Ask | 7.70 x 200 |
| Day's range | 7.60 - 8.20 |
| 52-week range | 5.90 - 11.08 |
| Volume | |
| Avg. volume | 167,006 |
| Market cap | 297.367M |
| Beta (5Y monthly) | 1.36 |
| PE ratio (TTM) | 30.64 |
| EPS (TTM) | 0.25 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.38 |
- GuruFocus.com
Viemed Healthcare Inc (VMD) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
Viemed Healthcare reports a significant revenue increase and strategic advancements, despite facing operational challenges and regulatory uncertainties.
- GuruFocus.com
Viemed Healthcare Inc (VMD) Q1 2024 Earnings: Revenue Surpasses Estimates, Net Income Falls Short
Insight into Viemed Healthcare's First Quarter Financial Performance
GlobeNewswireViemed Healthcare Announces First Quarter 2024 Financial Results
LAFAYETTE, La., May 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2024. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2024 were $50.6 million, representing an increase of $11.0 million, or 28%, over net revenu
© 2024 Yahoo. All rights reserved.